In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-γ/TNF-α

International Immunology

Volumn 16, Issue 12, 2004, Pages 1723-1732

  Qin, Hui Yu ^a   Chaturvedi, Pratibha ^a   Singh, Bhagirath ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c CANADIAN INSTITUTES OF HEALTH RESEARCH   (Canada)

Author keywords

Apoptosis; BCG; Cytokines; Immunoregulation; Mycobacterium; NOD mice; Type 1 diabetes

Indexed keywords

BCG VACCINE; CYTOKINE ANTIBODY; FAS ANTIGEN; FAS LIGAND; FREUND ADJUVANT; GAMMA INTERFERON; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETOGENESIS; DOWN REGULATION; GENE EXPRESSION; IMMUNIZATION; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MOUSE STRAIN; MYCOBACTERIUM; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; FAS LIGAND PROTEIN; IMMUNIZATION; IMMUNOTHERAPY, ACTIVE; INTERFERON TYPE II; INTERLEUKIN-4; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MYCOBACTERIUM BOVIS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECURRENCE; SPLEEN; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 10844224524     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxh173     Document Type: Article

References (49)

1. Sadelain, M. W. J., Qin, H.-Y., Lauzon, J. and Singh, B. 1990. Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39:583.
2. Yagi, H., Matsumoto, M., Suzuki, S., Misaki, S., Suzuki, R., Makino, S. and Harada, M. 1991. Possible mechanism of preventive effect of BCG against diabetes mellitus in NOD mice. Cell Immunol. 138:130.
3. Sadelain, M. W. J., Qin, H.-Y., Somoski, W., Parfrey, N., Singh, B. and Rabinovitch A. 1990. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmunity 3:671.
4. Qin, H.-Y. and Singh, B. 1997. BCG Vaccination Prevents Insulin-Dependent Diabetes Mellitus (IDDM) in NOD Mice after Disease Acceleration with Cyclophosphamide. J. Autoimmunity 10:271.
5. Ulaeto, D., Lacy, P. E., Kipnis, D. M., Kanagawa, O. and Unanue, E. R. 1992. AT cells dominant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc. Natl Acad. Sci. USA 89:3927.
6. Wang, T., Singh, B., Warnock, G. L. and Rajotte R. V. 1992. Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes 41:114.
7. Lakey, J. R., Singh, B., Warnock, G. L. and Rajotte R. V. 1994. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice. Transplantation 57:1213.
8. Qin, H.-Y., Sadelain, M. W. J., Hichon, C., Lauzon, J. and Singh, B. 1993. Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer diabetes in nonobese diabetic mice. J. Immunol. 150:80.
9. Shehadeh, N., Calcinaro, F., Bradley, B. J., Bruchilm, J., Vardi, P. and Lafferty, K. J. 1993. Effect of adjuvant therapy on development of diabetes in mouse and man. Lancet 43:706.
10. Rabinovitch, A., Suarez-Pinzon, W. L., Sorensen, O., Bleackley, R. C. and Power R. F. 1995. IFN-γ gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J. Immunol. 154:4874.
11. Rabinovitch, A. Sorensen, O., Suarez-Pinzon, W. L., Power, R. F., Rajotte, R. V. and Bleackley, R. C. 1994. Analysis of cytokine mRNA expression in syngeneic islet graft of NOD mice: interleukin 2 and interferon γ mRNA expression correlate with graft rejection and interleukin 10 with graft survival. Diabetologia 37:833.
12. Qin, H.-Y., Elliott, J. F., Lakey, J. R., Rajotte, R. V. and Singh, B. 1998. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy. J. Autoimmunity 11:591.
13. Serreze, D. V., Chapman, H. D., Post, C. M., Johnson, E. A., Suarez-Pinzon, W. L. and Rabinovitch, A. 2001. Th1 to Th2 cytokines shifts in Nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J. Immunol. 166:1352.
14. Hooks, G., Mackintosh. C. and Buchan, G. 1996. Activation of an interleukin-4 mRNA-producing population of peripheral blood mononuclear cells after infection with mycobacterium bovis or vaccination with killed, but not live BCG. Immunology 88:269.
15. Roch, F. and Bach, M. A. 1990. Strain differences in mouse cellular response to mycobacterium lepraemurium and BCG subcutaneous infections. I. Analysis of cell surface phenotype in local granulomas. Exp. Immunol. 80:332.
16. Sander, B., Skansen-Saphiru, U., Danim, O., Hakansson, L., Anderson, J. and Anderson, U. 1995. Sequential production of Th1 and Th2 cytokine in response to live Bacillus Calmette-Guerin. Immunology 4:512.
17. Orme, I. M., Roberts, A. D., Griffin, J. P. and Abrams, J. S. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to mycobacterium tuberculosis infection. J. Immunol. 151:518.
18. Dalton, D. K., Haynes, L., Chu, C.-Q., Swain, S. L. and Wittmer, S. 2000. Interferon γ eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J. Exp. Med. 192:117.
19. Sobel, D. O., Han, J., Williams, J., Yoon, J.-W., Jun, H.-S. and Ahvazi, B. 2002. Gamma interferon paradoxically inhibits the development of diabetes in the NOD mice. J. Autoimmunity 19:129.
20. Chu, C.-Q., Wittmer, S. and Dalton, D. K. 2000. Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis. J. Exp. Med. 191:123.
21. Zheng, L., Fisher, G., Miller, R. E., Peschon, J., Lynch, D. H. and Lenardo, M. J. 1995. Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348.
22. Ryu, S., Kodama, S., Ryu, K. and Faustman, D. L. 2001. Reversal of established autoimmune diabetes by restoration of endogenous beta cell function. J. Clin. Invest. 108:63.
23. Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O. and Acha-orbea, H. 1990. Prevention of Diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. Proc. Natl Acad. Sci. USA 87:968.
24. Campbell, I. L., Oxbrow, L. and Harrison, L. C. 1991. Reduction in insulitis following administration of IFN-γ and TNF-α in the NOD mice. J. Autoimmunity 4:249.
25. Christen, U., Wolfe, T., Mohrle, U., Hughes, A. C., Rodrigo, E., Green, E. A., Flavell, R. A. and Herrath, M. G. 2001. A dual role for TNF-alpha in type 1 diabetes: islet-specific expression abrogates the ongoing autoimmune process when induced late but not early during pathogenesis. J. Immunol. 166:7023.
26. Chervonski, A. V., Wang, Y., Wong, F. S., Visintin, I., Flavell, R. A., Janeway, C. A. and Matis, L. A. 1997. The role of Fas in autoimmune disease. Cell 89:17.
27. Zhang, X., Brunner, T., Carter, L., Dutton, R. W., Rogers, P., Bradly, L., Sato, T., Reed, J. C., Green, D. and Swain, S. L. 1997. Unequal Death in T cell (Th1) and Th2 effectors: Th1, but not Th2 effectors undergo rapid Fas/FasL-mediated apoptosis. J. Exp. Med. 10:1837.
28. Ramsdell, F., Seaman, M. S., Robert, R. E., Picha, K. S., Kennedy, M. K. and Lynch, D. H. 1994. Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation induced cell death. Int. Immunol. 6:1545.
29. Elzey, B. D., Griffith, T. S., Herndon, J. M., Barreiro, R., Tschopp, J. and Ferguson, T. A. 2001. Regulation of Fas ligand-induced apoptosis by TNF. J. Immunol. 167:3049.
30. Sytwu, H.-K., Liblau, R. S. and McDevitt H. O. 1996. The roles of Fas/APO-1 (CD95) and TNF in antigen-induced programmed cell death in T cell receptor transgenic mice. Immunity 5:17.
31. Qin, H.-Y., Suarez-Pinzon, WL., Parfrey, N., Power RF. and Rabinovitch, A. 1992. Mechanisms of Complete Freund's adjuvant protection against diabetes in BB rat: Induction of non-specific suppressor cells. Autoimmunity 12:193.
32. Delovitch, T. and Singh, B. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD. Immunity 7:727.
33. low CD4 cells correlated with cytokine profiles in spontaneously autoimmune diabetes mouse. Diabetes 45:71.
34. high expression as a marker. J. Immunol. 163:5708.
35. Anderson, P., Anderson, A. B., Sorensen, A. L. and Nagai, S. 1995. Recall of long-lived immunity to mycobacterium. J. Immunol. 154:3359.
36. Kim, S., Kim, K.-A., Hwang, D.-Y., Lee, T. H., Kayagaki, N., Yagita, H. and Lee, M.-S. 2000. Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved. J. Immunol. 164:2931.
37. Yagi, H., Matsumoto, M., Suzuki, S., Misaki, R., Suzuki, R., Makino, S. and Harada, M. 1991. Possible mechanism of preventative effect of BCG against diabetes mellitus in NOD mouse: I. Generation of suppressor macrophages in spleen cells of BCG-vaccinated mice. Cell Immunol. 138:130.
38. Lee, I.-F., Din, H., Trudeau, J., Dutz, J. and Tan, R. 2004. Regulation of autoimmune diabetes by complete Freund's adjuvant is mediated by NK cells. J. Immunol. 172:937.
39. Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N. and Williamson, B. 1975. An endotoxin-induced serum factor that cause necrosis of tumor. Proc. Natl Acad. Sci. USA 72:3666.
40. Green, S. J., Nacy, C. A., Schreiber, R. D., Granger, D. L., Crawford, R. M., Meltzer, M. S. and Fortier, A. H. 1993. Neutralization of gamma interferon and tumor necrosis factor alpha blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francislla tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61:689.
41. Winer, S., Tsui, H., Lau, A. et al. 2003. Autoimmune islet destruction in apontaneous type 1 diabetes is not β-cell exclusive. Nature Med. 9:198.
42. Del Prete, G. F., Tiri, A., De Carli, M., Mariotti, S., Pinchera, A., Chretien, S., Romagnani, S. and Ricci, M. 1989. High potential to tumor necrosis factor α (TNF-α) production of thyroid infiltrating lymphocytes in Hasimoto's thyroiditis: A peculiar feature of destructive thyroid autoimmunity. Autoimmunity 4:267.
43. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411.
44. Wang, J., Wakeham, J., Harkness, R. and Xing, Z. 1999. Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Investigation 103:1023.
45. Liesenfeld, O., Kosek, J. and Suzuki, Y. 1997. Gamma interferon induces Fas-dependant apoptosis of peyer's patch T cells in mice following personal infection with Toxoplasma gondii. Infect. Immun. 65:468.
46. Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway, C. A. and Flavell, R. A. 1996. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184:1963.
47. Rabinovitch, A., Suarez-Pinzon, W. L., Sorensen, O., Rajotte, R. V. and Power, R. F. 1997. TNF-α down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J. Immunol. 159:6298.
48. Martins, T. C. and Aguas, A. P. 1999. Mechanisms of mycobacterium avium-induced resistance against insulin-dependent diabetes mellitus (IDDM) in non-obese diabetic (NOD) mice: role of Fas and Th1 cells. Clin. Exp. Immunol. 115:248.
49. Hunger, R. E., Carnaud, C., Garcia, I., Vassalli, P. and Mueller, C. 1997. Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur. J. Immunol. 27:255.